Ken Griffin Acutus Medical, Inc. Transaction History

Citadel Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.17 - $0.74 $18,304 - $79,678	107,673 New	107,673 $21,000
Q2 2023 Aug 14, 2023	SELL	$0.66 - $1.02 $1,759 - $2,719	-2,666 Reduced 3.51%	73,265 $65,000
Q1 2023 May 15, 2023	BUY	$0.7 - $1.87 $33,247 - $88,817	47,496 Added 167.03%	75,931 $56,000
Q4 2022 Feb 14, 2023	BUY	$0.62 - $1.15 $17,629 - $32,700	28,435 New	28,435 $32,000
Q2 2022 Aug 15, 2022	BUY	$0.49 - $1.3 $25,769 - $68,368	52,591 Added 332.27%	68,419 $77,000

Q1 2022 May 16, 2022	SELL	$1.39 - $3.92 $12,332 - $34,778	-8,872 Reduced 35.92%	15,828 $22,000
Q4 2021 Feb 14, 2022	SELL	$3.1 - $8.97 $114,923 - $332,535	-37,072 Reduced 60.01%	24,700 $84,000
Q3 2021 Nov 15, 2021	BUY	$8.35 - $16.99 $361,529 - $735,616	43,297 Added 234.35%	61,772 $546,000
Q2 2021 Aug 16, 2021	BUY	$11.59 - $17.73 $214,125 - $327,561	18,475 New	18,475 $313,000
Q4 2020 Feb 16, 2021	SELL	$22.87 - $32.1 $2.16 Million - $3.03 Million	-94,502 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$24.5 - $37.65 $2.32 Million - $3.56 Million	94,502 New	94,502 $2.82 Million

6.67M

Ticker AFIB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,370,300
Market Cap $1.7M
Description
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conv...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.